NRAS and colorectal carcinoma: The 205 CRC cases included 13 cases with BRAF mutation, 59 with KRAS mutation only, 56 with NRAS‐mutation only, 5 with both KRAS and NRAS mutations, and 72 with no mutation of these oncogenes (Table S2).